Skip to content
Winfred
Sign up
Back to Investors
CI

Cedars-Sinai Intellectual Property Company

Corporate
Follow

Portfolio

1

companies

By category

  • AI/ML£1.6M

By location

  • London£1.6M

Portfolio companies

NH

Neu Health

Neu Health builds a digital care platform for neurology patients.

Team

SM

Shlomo Melmed

executive vice president of Medicine & Health Sciences and dean of the Medical Faculty

James Laur

James Laur

chief executive

James serves as chief executive of Cedars-Sinai Intellectual Property Company and managing director of Cedars-Sinai Health Ventures. He also holds board positions across diagnostic and biotechnology companies.

LinkedIn

Recent investments

Seed
£1.6M

Neu Health raises £1.6m from Cedars-Sinai and Oxford Science Enterprises to pilot its neurology platform in the US

AI/MLHealthTechMobile App

Cedars-Sinai and Oxford Science Enterprises backed the seed round to support expansion into the American market.

"The research produced at Oxford is of the highest caliber. An ongoing relationship with OSE will serve our patients and also strengthen the academic and clinical missions of Cedars-Sinai."
— Shlomo Melmed, executive vice president of Medicine & Health Sciences and dean of the Medical Faculty
NH
Neu Health— London, UK Follow
CI
Oxford Science Enterprises
Cedars-Sinai Intellectual Property Company + 1 other